Leadership changes, November 2026

Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.

Updated Nov 6, 2026

Changes

287

Appointments

163

Departures

Browse by role

November 2026

Get new CFO appointments the day the filing lands.

Leadership changes, November 2026
Filing date	Company	Person	Role	Change	Effective date	Source
Nov 2, 2026	UPWORK, INC	Peter Sanborn	Chief Financial Officer (“CFO”) and principal financial officerCFO	Appointed	Jan 1, 2027	SEC 8-K
Nov 2, 2026	UR-ENERGY INC	Roger L. Smith	Chief Financial Officer and Chief Administrative OfficerCFO	Departed	Dec 1, 2026	SEC 8-K
Nov 2, 2026	UR-ENERGY INC	Jade Walle	Chief Financial OfficerCFO	Appointed	n/a	SEC 8-K
Nov 2, 2026	Valion Bio, Inc.	Melinda Lackey	General Counsel and Senior Vice President of Legal AffairsCLO	Departed	Oct 30, 2026	SEC 8-K
Nov 2, 2026	Xeris Biopharma Holdings, Inc.	Menassie Taddese	Class II directorClass II director	Appointed	Nov 2, 2026	SEC 8-K
Nov 2, 2026	ZIPRECRUITER, INC.	Emily McEvilly	DirectorDirector	Departed	Oct 29, 2026	SEC 8-K
Nov 2, 2026	ZIPRECRUITER, INC.	Jeffrey Liaw	Class III directorClass III director	Appointed	Oct 29, 2026	SEC 8-K

UPWORK, INCAppointed
Peter Sanborn CFO
Filed Nov 2, 2026Effective Jan 1, 2027SEC 8-K
UR-ENERGY INCDeparted
Roger L. Smith CFO
Filed Nov 2, 2026Effective Dec 1, 2026SEC 8-K
UR-ENERGY INCAppointed
Jade Walle CFO
Filed Nov 2, 2026SEC 8-K
Valion Bio, Inc.Departed
Melinda Lackey CLO
Filed Nov 2, 2026Effective Oct 30, 2026SEC 8-K
Xeris Biopharma Holdings, Inc.Appointed
Menassie Taddese Class II director
Filed Nov 2, 2026Effective Nov 2, 2026SEC 8-K
ZIPRECRUITER, INC.Departed
Emily McEvilly Director
Filed Nov 2, 2026Effective Oct 29, 2026SEC 8-K
ZIPRECRUITER, INC.Appointed
Jeffrey Liaw Class III director
Filed Nov 2, 2026Effective Oct 29, 2026SEC 8-K